Ontario life sciences startup, Allarta, receives award from JDRF to advance its work in creating a functional cure for type 1 diabetes
Allarta Life Science, a regenerative medicine company using novel hydrogels to enable cell-based therapies for type 1 diabetes (T1D), has received an award from JDRF, the leading global T1D research and advocacy organization.